| 1 |
6629593 | Oral administration of the methanol extraction residue of BCG (MER/BCG): a phase I study in non-oat cell lung cancer patients. | 1983 |
1 |
| 2 |
6181041 | A prospective controlled evaluation of combined pelvic radiotherapy and methanol extraction residue of BCG (MER) for locally unresectable or recurrent rectal carcinoma. | 1982 Jul |
1 |
| 3 |
6266642 | Combination chemotherapy with and without the methanol-extracted residue of bacillus Calmette-Guerin (MER) in extensive non-small-cell lung cancer: a prospective randomized study for the Piedmont Oncology Association. | 1981 Jun 15 |
1 |
| 4 |
7226124 | Chemotherapy vs. chemoimmunotherapy with methanol extraction residue of Bacillus Calmette-Guerin (MER) in advanced breast cancer: a randomized trial by the Piedmont Oncology Association. | 1981 May 1 |
1 |
| 5 |
6249481 | Evaluation of vindesine and MER in colorectal cancer. | 1980 Aug 1 |
1 |
| 6 |
204612 | Effects of prophylactic treatment with the methanol extraction residue fraction of tubercle bacilli (MER) on the development of Rous sarcomas of chickens following challenge with the Rous sarcoma virus. | 1978 Jan |
2 |
| 7 |
728866 | Intralesional injection of the methanol extraction residue of Bacillus Calmette-Guerin (MER) into cutaneous metastases of malignant melanoma. | 1978 Dec |
2 |
| 8 |
336070 | A preliminary study of intravenous methanol extraction residue of BCG in treatment of advanced cancer. | 1977 Sep |
1 |
| 9 |
1218995 | Proceedings: Recent studies with the methanol extraction residue fraction of tubercle bacilli (MER): efficacy of distal administration against solid tumors of experimental animals, and stimulation of cellular immunologic responsiveness in cancer patients. | 1975 Dec |
1 |